99% Savings - Buy Just @1 Rs X
Magnatuss A is a commercial drug that is prescribed in the form of Syrup. Secondary and off-label uses of Magnatuss A have also been mentioned below.
The optimal dosage of Magnatuss A is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
The most common side effects of Magnatuss A are Constipation, Heartburn. Apart from the aforementioned side effects, Magnatuss A can also lead to other problems, which have been listed below. Usually, these side effects of Magnatuss A go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Magnatuss A is Severe for pregnant women and Severe for women who are breastfeeding. It is important to know if Magnatuss A has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Magnatuss A related warnings section.
Magnatuss A is not recommended if you suffer from certain medical conditions as it can have adverse effects. Asthma, Smoking Addiction, Gastrointestinal Bleeding are examples of such conditions. Some other conditions that can be affected by Magnatuss A are listed in the contraindications section below.
Drug interactions for Magnatuss A have been reported in the medical literature. Refer to the list below for further details.
In addition to these precautions, you may also note that Magnatuss A is safe while driving, and is is addictive in nature.
Magnatuss A is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Magnatuss A safe for pregnant women?
Magnatuss A has many dangerous side effects in pregnant women. If you are pregnant, do not consume Magnatuss A without medical advice.
Is the use of Magnatuss A safe during breastfeeding?
Magnatuss A should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Magnatuss A on the Kidneys?
Magnatuss A rarely affects the kidneys.
What is the effect of Magnatuss A on the Liver?
Magnatuss A has very mild side effects on the liver.
What is the effect of Magnatuss A on the Heart?
Side effects of Magnatuss A rarely affect the heart.
Magnatuss A should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Magnatuss A unless your doctor advises you to do so -
Is this Magnatuss A habit forming or addictive?
No, there is no any evidence that Magnatuss A is addictive.
Interaction between Food and Magnatuss A
Information is not available on the interaction of any foods with Magnatuss A , due to a lack of research on this.
Interaction between Alcohol and Magnatuss A
Information about the interaction of Magnatuss A and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Claritin® (loratadine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 164,166
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 790-791
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Guaifenesin
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 629-631
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 219